318 related articles for article (PubMed ID: 33340617)
1. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
[TBL] [Abstract][Full Text] [Related]
2. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARĪ± pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
3. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
4. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
5. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
Wang C; Chen Z; Yi Y; Ding Y; Xu F; Kang H; Lin K; Shu X; Zhong Z; Zhang Z; Liu J; Xu Z; Liu L; He X; Chang Y; Zhao Q
Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
[TBL] [Abstract][Full Text] [Related]
6. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.
Feng T; Li S; Zhao G; Li Q; Yuan H; Zhang J; Gu R; Ou D; Guo Y; Kou Q; Wang Q; Li K; Lin P
Cell Oncol (Dordr); 2023 Oct; 46(5):1235-1252. PubMed ID: 37052853
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.
Cui M; Xiao Z; Sun B; Wang Y; Zheng M; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Mar; 445(3):651-5. PubMed ID: 24576478
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth.
Wang C; Tong Y; Wen Y; Cai J; Guo H; Huang L; Xu M; Feng M; Chen X; Zhang J; Wu H; Kong X; Xia Q
Hepatology; 2018 Nov; 68(5):1833-1850. PubMed ID: 29663480
[TBL] [Abstract][Full Text] [Related]
9. Sperm associated antigen 4 promotes SREBP1-mediated de novo lipogenesis via interaction with lamin A/C and contributes to tumor progression in hepatocellular carcinoma.
Liu T; Yu J; Ge C; Zhao F; Chen J; Miao C; Jin W; Zhou Q; Geng Q; Lin H; Tian H; Chen T; Xie H; Cui Y; Yao M; Xiao X; Li J; Li H
Cancer Lett; 2022 Jun; 536():215642. PubMed ID: 35307486
[TBL] [Abstract][Full Text] [Related]
10. ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription.
Wu D; Zuo Z; Sun X; Li X; Yin F; Yin W
Biochem Pharmacol; 2024 Jun; 224():116206. PubMed ID: 38615921
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Ndiaye H; Liu JY; Hall A; Minogue S; Morgan MY; Waugh MG
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32286604
[TBL] [Abstract][Full Text] [Related]
12. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
Wang J; Wang Z; Yuan J; Wang J; Shen X
Aging (Albany NY); 2020 May; 12(9):7786-7800. PubMed ID: 32357142
[TBL] [Abstract][Full Text] [Related]
13. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
[TBL] [Abstract][Full Text] [Related]
14. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
Meng H; Shen M; Li J; Zhang R; Li X; Zhao L; Huang G; Liu J
Eur J Pharmacol; 2021 Sep; 906():174280. PubMed ID: 34174265
[TBL] [Abstract][Full Text] [Related]
15. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol attenuated the progression of DEN-induced hepatocellular carcinoma via inhibiting SCAP mediated fatty acid de novo synthesis.
Zhao Z; Zhong L; He K; Qiu C; Li Z; Zhao L; Gong J
Biochem Biophys Res Commun; 2019 Feb; 509(4):855-861. PubMed ID: 30638930
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatoma-derived growth factor in promoting deĀ novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
18. Acyl-CoA thioesterase 9 promotes tumour growth and metastasis through reprogramming of fatty acid metabolism in hepatocellular carcinoma.
Wang B; Zhang H; Chen YF; Hu LQ; Tian YY; Tong HW; Wang G; Chen C; Yuan P
Liver Int; 2022 Nov; 42(11):2548-2561. PubMed ID: 36004563
[TBL] [Abstract][Full Text] [Related]
19. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
20. ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis.
Chen J; Ding C; Chen Y; Hu W; Lu Y; Wu W; Zhang Y; Yang B; Wu H; Peng C; Xie H; Zhou L; Wu J; Zheng S
Oncogenesis; 2020 Apr; 9(4):42. PubMed ID: 32350243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
